Back to discover
Disease
Hereditary Complement Deficiency Diseases
Emerging research
1
Publications
2020
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection.
Research2020-08-03Nature medicine
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
No activity recorded in this window. Try a wider timeframe.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Most influential
Leading journals1
- Nature medicine1
Leading researchers8
- Butler D1
- De Freitas JK1
- Foox J1
- Glicksberg BS1
- Kim J1
- Mason CE1
- May B1
- Meydan C1
Affiliations (unnormalised)6
- Columbia University1
- Hasso Plattner Institute for Digital Health at Mount Sinai1
- Herbert Irving Comprehensive Cancer Center1
- Icahn School of Medicine at Mount Sinai1
- The Feil Family Brain and Mind Research Institute1
- The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine1
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
Genetic disorders due to mutations in genes involved in COMPLEMENT SYSTEM PROTEINS. They are often classified into distinct pathway of complement activation where causative mutations are found (e.g., classical pathway, lectin pathway, alternative pathway, and terminal complement pathway).
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.